OWP Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 E Diehl Rd Ste 400, Naperville, Illi...Phone Number
(800) 273-6729Website
www.owppharma.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About OWP Pharmaceuticals
OWP Pharmaceuticals delivers quality branded generic epilepsy medications that are replicable and fairly priced. The company's strategic focus is to support neurologists and patients in the U.S. with beneficial products and to use the majority of the profits to provide resources for those living with epilepsy in under-resourced areas of the world, by donating to the ROW Foundation. How and why does OWP Pharmaceuticals strategically partner with the nonprofit ROW Foundation? OWP Pharmaceuticals was founded on drastically different values than most companies. It is not to maximize profits for shareholders, but instead to harness the power and efficiency of the free market to make the world a better place. The company refer to this as Social Enterprise 2.0. The company designed a two-track solution to reach the company's goals; a market-based company to harness the marketplace and a not-for-profit organization to direct this financial power to needy parts of the world. The company is commRead more
OWP Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OWP Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when OWP Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at OWP Pharmaceuticals
Funding: Get notified immidiatlly once OWP Pharmaceuticals has new funding data
Click to see if OWP Pharmaceuticals had a recent Job posting/layoffs
OWP Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on OWP Pharmaceuticals recently announced quarterly report
Check if OWP Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if OWP Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at OWP Pharmaceuticals
Find more new buyers
Compare Similar Companies to OWP Pharmaceuticals
Compare insights from companies similar to OWP Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OWP Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OWP Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OWP Pharmaceuticals.
OWP Pharmaceuticals financials insights
Gather financial insights about OWP Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$201K
2025
Private Equity
$2.4M
OWP Pharmaceuticals Tech Stack
A closer look at the technologies used by OWP Pharmaceuticals
See more technologies
Most Recent Scoops
Hiring Plans
OWP Pharmaceuticals has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: Zoom.
Hiring Plans
Open Position
Funding
Funding
Funding
OWP Pharmaceuticals News & Media
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE® (lamotrigine) Oral Suspension
Novel therapy for epilepsy and bipolar disorders received FDA approval in September CHICAGO, Oct. 23, 2025 /PRNewswire/ -- OWP Pharmaceuticals, a privately held, commercial-stage neuroscience specialty pharmaceutical company, today announced that EVERSANA®, a leading provider of...OWP Pharmaceuticals Announces FDA Approval of SUBVENITE® Oral Suspension
The First and Only Lamotrigine Oral Suspension in the U.S. LISLE, IL, UNITED STATES, September 17, 2025 /EINPresswire.com/ -- OWP Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved SUBVENITE® Oral Suspension, …OWP Pharmaceuticals Announces IND Authorization for First Oral Liquid Formulation of Trazodone for Treatment of MDD
NAPERVILLE, ILLINOIS, UNITED STATES, August 1, 2023 /EINPresswire.com/ -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and commercializing novel oral liquid …OWP Pharmaceuticals Announces Patent Application for First Oral Liquid Formulation of Trazodone for Treatment of MDD
OWP has applied for U.S. patent protection for the first-ever oral solution of trazodone, the sixth liquid medication that the company hopes to commercialize. NAPERVILLE, ILLINOIS, USA, November 30, 2022 /EINPresswire.com/ -- OWP Pharmaceuticals, Inc. …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OWP Pharmaceuticals
Sign Up For FreeTo access detailed company insights
OWP Pharmaceuticals delivers quality branded generic epilepsy medications that are replicable and fairly priced. The company's strategic focus is to support neurologists and patients in the U.S. with beneficial products and to use the majority of the profits to provide resources for those living with epilepsy in under-resourced areas of the world,... Read More
